Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Prospective, Open-label Feasibility Study of Radiotherapy Dose Escalation for the Non-operative Management of Patients With Unresectable Locally Recurrent Rectal Cancer

NCT07721181 is registered in ClinicalTrials.gov with Heike M.U. Peulen as lead sponsor.

NCT NCT07721181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07721181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Prospective, Open-label Feasibility Study of Radiotherapy Dose Escalation for the Non-operative Management of Patients With Unresectable Locally Recurrent Rectal Cancer
Lead sponsor
Heike M.U. Peulen
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2026
Completion date
December 31, 2031
Enrollment
30 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

locally recurrent rectal cancer